As diabetes care continues to be a crucial focus, innovative treatments are appearing . Retatrutide, Tirzepatide, and Semaglutide represent a exciting generation in GLP-1 receptor agonist medications. While https://bookmarkusers.com/story21942889/the-new-drug-vs-that-medication-vs-this-injection-a-direct-analysis